Stay ahead in the rapidly evolving LNP space with the 4 th LNP Formulation & Process Development Summit—the largest global meeting dedicated purely to LNPs. The official event guide is your must-have ...
In contrast, polyethylene glycol (PEG)-lipid standards, commonly used in current LNP formulations, elicited a strong and boosted antibody response. Anti-PEG antibodies have been implicated as a ...
Unlocking the therapeutic applicability of LNP-mRNA: chemistry, formulation, and clinical strategies
LNP as the novel drug delivery system enhancing mRNA therapeutic efficacy has been proved for its delivery ability. This review provides valuable insights into the current state-of-the-art of LNP mRNA ...
A new study shows lipid nanoparticles can be formulated at much higher lipid concentrations using a modular mixing approach, ...
Particle Works offers a range of automated microfluidic systems that ensure robust laboratory processes and easy control of microfluidic parameters. Automated LNP formulation enables rapid and precise ...
From global vaccines to personalized cancer therapies, mRNA is being considered across several clinical applications, which ultimately creates varying requirements in terms of production scale and ...
In this free webinar, gain insight into the principles of mRNA and LNP technology and their unique advantages for in vivo CAR T-cell development. Attendees will learn how mRNA synthesis, LNP ...
COLCHESTER, Vt.--(BUSINESS WIRE)--Vernal Biosciences, a leading manufacturing and services company specializing in mRNA and lipid nanoparticle (LNP) formulation, proudly announces the additions of ...
HUNTSVILLE, AL, April 15, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics (SER), Inc. , a clinical-stage biotechnology company developing its proprietary POZ Platform ...
Vernal Biosciences, a leading manufacturing and services company specializing in mRNA and lipid nanoparticle (LNP) formulation, proudly announces the additions of Sven Lee, Chief Commercial Officer, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results